×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

13-F Portfolio Value: $34.54 M
Last 13-F Filed: Q2 2025
Concentration in top 10: 100%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
FBRXFORTE BIOSCIENCES INC (FBRX US)29.45%786,647$10,171,346166,66626.88%$12.9313F
TSHATAYSHA GENE THERAPIES INC (TSHA US)27.39%4,095,000$9,459,450395,00010.68%$2.3113F
BCYCBICYCLE THERAPEUTICS LTD-ADR (BCYC US)20%993,743$6,906,514417,40072.42%$6.9513F
ZNTLZENTALIS PHARMACEUTICALS INC (ZNTL US)4.96%1,478,152$1,714,656516,66653.74%$1.1613F